RNTX

Rein Therapeutics, Inc. Common Stock
RNTX

Overview Fund Activity

52 hedge funds and large institutions have $48M invested in Rein Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 14 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+22
Holders Change %
+73.33%
% of All Funds
0.92%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
24
Increased
14
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AIM
1
Alerce Investment Management
Illinois
$23.8M
2
BI
2
BVF Inc
California
$7.53M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$5.23M
4
IC
4
Ikarian Capital
Texas
$4M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$1.79M

Top Sellers

1
Qube Research & Technologies (QRT)
1
Qube Research & Technologies (QRT)
United Kingdom
$18K
2
Goldman Sachs
2
Goldman Sachs
New York
$0
3
GCP
3
GSA Capital Partners
United Kingdom
$119K
4
Bank of America
4
Bank of America
North Carolina
$15K
5
CAPTRUST Financial Advisors
5
CAPTRUST Financial Advisors
North Carolina
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
VFA
51
Valeo Financial Advisors
Indiana
$1K +$1K +50 New
MIH
52
Meitav Investment House
Israel
$16 +$16 +550 New
Goldman Sachs
53
Goldman Sachs
New York
– -$35K -1,660 Closed
CAPTRUST Financial Advisors
54
CAPTRUST Financial Advisors
North Carolina
– -$1K -65 Closed
1 2
3